Hemoglobin Levels in Patients with Human Immunodeficiency Virus Na ve Therapy Containing Zidovudine in the First Three Months

Background: Zidovudine, one of the combination antiretroviral used to treat HIV/AIDS, is the most common cause of anemia in HIV patients. Anemia related to zidovudine in HIV can worsen HIV infection. This study determined the hemoglobin level and effect of zidovudine therapy on HIV naïve patients in...

Full description

Saved in:
Bibliographic Details
Main Authors: PRASETYANING ESTU PRATIWI, NIM011418026311, Usman Hadi, -, Muhammad Vitanata Arfijanto, -
Format: Article PeerReviewed
Language:English
English
English
Published: EManuscript Technologies 2020
Subjects:
Online Access:https://repository.unair.ac.id/126549/1/05%20artikel.pdf
https://repository.unair.ac.id/126549/2/05%20Karil.pdf
https://repository.unair.ac.id/126549/3/05%20Turnitin.pdf
https://repository.unair.ac.id/126549/
https://www.sysrevpharm.org/abstract/hemoglobin-levels-in-patients-with-human-immunodeficiency-virus-nave-therapy-containing-zidovudine-in-the-first-three-mo-65525.html
http://dx.doi.org/10.5530/srp.2019.2.04
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
English